.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Novartis
Deloitte
McKesson
Argus Health
Farmers Insurance
US Army
Daiichi Sankyo
Johnson and Johnson

Generated: June 27, 2017

DrugPatentWatch Database Preview

ZIPRASIDONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Ziprasidone Hydrochloride, and what generic Ziprasidone Hydrochloride alternatives are available?

Ziprasidone Hydrochloride is a drug marketed by Aurobindo Pharma Ltd, Wockhardt Ltd, Lupin Pharms, Apotex Inc, Sandoz Inc, Dr Reddys Labs Inc, Macleods Pharms Ltd, and Mylan Pharms Inc. and is included in eight NDAs.

The generic ingredient in ZIPRASIDONE HYDROCHLORIDE is ziprasidone hydrochloride. There are twenty-one drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the ziprasidone hydrochloride profile page.

Summary for Tradename: ZIPRASIDONE HYDROCHLORIDE

Patents:0
Applicants:8
NDAs:8
Suppliers / Packagers: see list26
Bulk Api Vendors: see list162
Clinical Trials: see list2,367
Patent Applications: see list3,394
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZIPRASIDONE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: ZIPRASIDONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL202395-004Oct 10, 2013ABRXNoNo► Subscribe► Subscribe
Macleods Pharms Ltd
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL204375-004Feb 17, 2017ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL202395-001Oct 10, 2013ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL204117-001Dec 27, 2016ABRXNoNo► Subscribe► Subscribe
Sandoz Inc
ZIPRASIDONE HYDROCHLORIDE
ziprasidone hydrochloride
CAPSULE;ORAL077562-002Jun 1, 2012ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Harvard Business School
Covington
Farmers Insurance
Julphar
Cipla
Fuji
Boehringer Ingelheim
US Army
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot